Indication and important safety information INCRELEX (mecasermin) is indicated for the treatment of growth failure in pediatric patients aged 2 years and older with severe primary IGF-1 deficiency* (IGFD), or with hormone (GH) gene deletion who have developed neutralizing antibodies to GH
Patients are thoroughly evaluated beforehand to ensure the therapy aligns with their overall health goals, minimizing risk while maximizing benefits
As low as with 6-month plan One of the strongest weightloss momentum for many adultsdualaction GLP1/GIP with a simple, onceweekly routine
The complexion regains optimal density, velvety softness, a perfectly even tone, and a healthy, youthful, and radiant appearance
DARK SPOT & RADIANT COMPLEXION CARE: Powered by KFDA-approved Niacinamide and Vitamin C derivative SAP, this Korean skincare cream helps reduce dark spots and discoloration, improves uneven tone, and promotes a luminous, radiant glow
Knowing your TDEE reminds you of this fact its not magic, its science